Results from a 19 year international study with 3,708 patients with Type 2 diabetes, men and women, 25-to-74 years old, has shown that increasing physical activity reduced the risk of death for men and women of all ages, smokers and nonsmokers alike, regardless of body mass index, blood pressure or …

Respondents who knew their HbA1c values reported better diabetes care understanding and assessment of their glycemic control than those who did not.

A biomarker that can detect acute renal failure (ARF) just a few hours after onset has been discovered.

HbA1c levels are directly related to the severity of erectile dysfunction (ED) in diabetic men.

A man’s waistband may provide a big clue about his risk for diabetes.

Fructose infusion can help restore the impaired counterregulatory response to hypoglycemia seen in many type 1 diabetes patients.

Healthy young adults who are chronic “short sleepers”—getting an average of about 5 hours of sleep a night—must secrete 30% more insulin than other adults to achieve a normal glucose curve.

The FDA issued an approvable letter for Glumetza, a once-daily, extended-release version of the diabetes drug metformin.

Results of a new study provide more evidence, in a larger population of patients, that the combination of a fibrate and a statin is an effective therapeutic option for managing combined hyperlipidemia — that is, elevated triglycerides and LDL-C and multiple lipoprotein abnormalities.

The results of a new study indicate that pioglitazone is superior to gliclazide in sustaining glycemic control for up to two years in type 2 diabetics.